about
Acquired Gitelman Syndrome in an Anti-SSA Antibody-positive Patient with a SLC12A3 Heterozygous Mutation.A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.Cell cycle regulation therapy combined with cytokine blockade enhances antiarthritic effects without increasing immune suppression.Clinical significance of complement as a biomarker of disease activity in 4 cases of IgG4-related disease with retroperitoneal fibrosis.Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections.Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).Successful use of rituximab in a patient with refractory thrombotic thrombocytopaenic purpura complicated by polymyositis.[TNF and TNF receptor signaling pathway]Identification of Compounds That Prolong Type I Interferon Signaling as Potential Vaccine AdjuvantsInduction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist
P50
Q37478931-AA78668F-0CB8-49C5-A322-6CFF5BC92485Q40142995-DE0B221D-6001-444F-83D4-502990ACD96FQ41886564-66F4AD38-2947-48F3-8B1A-80F3D48DC586Q43473208-8C706F9C-FD4F-4332-87D9-260A3A616C9EQ43546744-FEB759CA-9098-4D9C-BE6A-F20E4945F76EQ43806215-5FB426B5-5E94-4BE6-B251-7F00A4A04616Q44297178-DA7CD503-86A8-473E-9E48-7F81D950E50EQ48558967-ED084C45-A672-4776-94AC-69966B8A35E9Q51700303-752C6237-6D7E-41DD-84D3-5068CA8CF4E2Q86437030-099101AE-A0FE-4E2B-B125-CFE581F42D10Q88643840-4914B801-5BA4-4B7D-92CC-7C54252E9FA1Q89393186-C3E09E11-E0E7-45E5-B7DB-2271A1B9442B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tadashi Hosoya
@ast
Tadashi Hosoya
@en
Tadashi Hosoya
@es
Tadashi Hosoya
@nl
type
label
Tadashi Hosoya
@ast
Tadashi Hosoya
@en
Tadashi Hosoya
@es
Tadashi Hosoya
@nl
prefLabel
Tadashi Hosoya
@ast
Tadashi Hosoya
@en
Tadashi Hosoya
@es
Tadashi Hosoya
@nl
P106
P31
P496
0000-0001-5177-6413